The government’s Rs 1,500 crore bet on Biological E’s vaccine candidate that is still undergoing trials may be a risk worth taking, experts said but an industry executive said the money should have been used to buy vaccines already in the marketIs the govt taking a risk on Bio E vaccine that#39;s yet to cross the finish line?
The government’s Rs 1,500 crore bet on Biological E’s vaccine candidate that is still undergoing trials may be a risk worth taking, experts said but an industry executive said the money should have been used to buy vaccines already in the market
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The bank plans to raise up to Rs 500 crore by issue of equity shares to qualified institutional buyers through qualified institutional plac...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment